全部 标题 作者
关键词 摘要

OALib Journal期刊
ISSN: 2333-9721
费用:99美元

查看量下载量

相关文章

更多...

Diagnostic Evaluation of Myelodysplastic Syndromes (MDS) in the Democratic Republic of Congo: A Review of Current Practices and Challenges

DOI: 10.4236/ojbd.2025.153012, PP. 117-123

Keywords: Diagnosis, Myelodysplastic Syndromes, Haematology, Democratic Republic of Congo, Health Systems

Full-Text   Cite this paper   Add to My Lib

Abstract:

Background and Aim: Myelodysplastic syndromes (MDS) are a heterogeneous group of clonal disorders characterised by ineffective haematopoiesis and an increased risk of progression to acute myeloid leukaemia. In the Democratic Republic of Congo (DRC) healthcare institutions face major diagnostic challenges due to minimal infrastructure, limited access to testing equipment and a shortage of trained professionals. This study analyses current MDS diagnostic practices in the DRC, identifies unmet needs and proposes strategies for improving early and accurate detection. Methods: A comprehensive literature review was conducted using international databases (PubMed, Google Scholar and Scopus) alongside local health reports. Peer-reviewed articles, hospital-based studies and World Health Organization (WHO) guidelines were synthesised, with a focus on MDS diagnosis in sub-Saharan Africa and the DRC. Grey literature, including ministry of health reports and National Laboratory assessments, was also examined. Results: The findings reveal persistent diagnostic barriers in the DRC, including limited availability of bone marrow aspiration tools, under-resourced laboratories and a lack of trained haematopathologists. MDS diagnosis largely depends on peripheral blood analysis and basic marrow examinations, leading to frequent underdiagnosis and misclassification. The absence of standardised diagnostic protocols and inconsistent reporting practices further hampers accurate disease identification. Misdiagnosis can occur when nutritional deficiencies, such as copper or vitamin B?? deficiency—present with cytopenias and dysplastic changes that mimic MDS. Conclusion: MDS diagnostic evaluation in the DRC is hindered by systemic and technical limitations including infrastructure deficits and workforce shortages. There is an urgent need for a national diagnostic guideline tailored to the DRC’s healthcare context and a tiered diagnostic framework that aligns basic, district-level and tertiary-level investigations. Addressing these issues requires strengthening laboratory capacity, expanding access to diagnostic technologies and investing in specialist training through international collaborations and local educational initiatives.

References

[1]  Waldrop, G., Goetz, T.G., Siddiqi, O.K., Koralnik, I.J., Shah, H. and Thakur, K.T. (2019) The World Health Organization’s Essential Diagnostics List. Neurology, 93, 680-683.
https://doi.org/10.1212/wnl.0000000000008247
[2]  Al-Haidose, A., Yassin, M.A., Ahmed, M.N., Kunhipurayil, H.H., Al-Harbi, A.A., Aljaberi, M.A., et al. (2023) Distinct Clinical and Prognostic Features of Myelodysplastic Syndrome in Patients from the Middle East, North Africa, and beyond: A Systemic Review. Journal of Clinical Medicine, 12, Article 2832.
https://doi.org/10.3390/jcm12082832
[3]  African Society for Laboratory Medicine (ASLM) (2024) Status Report on Laboratory Leadership in Africa. This Report Uses Desk Reviews, Surveys and Interviews with Stakeholders across Sub Saharan Africa and Highlights Gaps in Leadership and Governance of National Laboratory Networks.
[4]  Singh, G., Goswami, K., Farooq, A., Trehan, S., Arora, R.S., Bector, G., et al. (2024) Copper Deficiency Mimicking Myelodysplastic Syndrome: A Case Report. Cureus, 16, e66765.
https://doi.org/10.7759/cureus.66765
[5]  Jamil, M., Nasser, Z., Jamil, D., Sheqwara, J.Z. and Langabeer, S.E. (2024) Unmasking Vitamin B12 Deficiency Misdiagnosed as Myelodysplastic Syndrome. Case Reports in Hematology. Wiley, 4, 2 (Cases Reports 1 and 2).
https://doi.org/10.1155/2024/3258227
[6]  Heidt, B., Siqueira, W., Eersels, K., Diliën, H., van Grinsven, B., Fujiwara, R., et al. (2020) Point of Care Diagnostics in Resource-Limited Settings: A Review of the Present and Future of POC in Its Most Needed Environment. Biosensors, 10, Article 133.
https://doi.org/10.3390/bios10100133
[7]  Kuupiel, D., Bawontuo, V., Drain, P.K., Gwala, N. and Mashamba-Thompson, T.P. (2019) Supply Chain Management for Point of care Tests in Low Income Countries: A Scoping Review. The Review Found That Most Low Income Country Studies Reported Stock Outs of Poc Tests Due to Supply CHAIN Failures. BMC Health Services Research, 19, Article No. 519.
https://doi.org/10.1186/s12913-019-4351-3
[8]  O’Neill, K., Takane, M., Sheffel, A., Abou-Zahr, C. and Boerma, T. (2013) Monitoring Service Delivery for Universal Health Coverage: The Service Availability and Readiness Assessment. Bulletin of the World Health Organization, 91, 923-931.
https://doi.org/10.2471/blt.12.116798

Full-Text

Contact Us

service@oalib.com

QQ:3279437679

WhatsApp +8615387084133